Recall-feed
Recente FDA-recalls
Over geneesmiddelen, hulpmiddelen, supplementen en cosmetica. Meest recent eerst. Bron: openFDA enforcement.
100 van 100 getoond
| Datum ↓ | Middel | Klasse | Reden | Bedrijf |
|---|---|---|---|---|
| 9 mei 2022 | nicotinamide | II | Lack of assurance of sterility. | Olympia Compounding Pharmacy dba Olympia Pharmacy |
| 9 mei 2022 | nicotinamide | II | Lack of assurance of sterility. | Olympia Compounding Pharmacy dba Olympia Pharmacy |
| 9 mei 2022 | glutathione | II | Lack of assurance of sterility. | Olympia Compounding Pharmacy dba Olympia Pharmacy |
| 8 apr 2019 | glutathione | II | Lack of assurance of sterility for injectables and solutions intended to be sterile. | Customceutical Compounding |
| 7 mrt 2022 | glutathione | II | Lack of Assurance of Sterility | TMC Acquisition LLC dba Tailor Made Compounding |
| 7 mrt 2022 | glutathione | II | Lack of Assurance of Sterility | TMC Acquisition LLC dba Tailor Made Compounding |
| 6 okt 2014 | glutathione | II | Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection. | Oregon Compounding Centers, Inc. dba Creative Compounds |
| 6 okt 2014 | glutathione | II | Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection. | Oregon Compounding Centers, Inc. dba Creative Compounds |
| 5 sep 2014 | glutathione | I | Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing facility indicating that the products may not be sterile. | Pharmacy Creations |
| 30 nov 2020 | copper peptide | II | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile. | Advanced Nutriceuticals, LLC |
| 30 jul 2025 | glutathione | II | Lack of Assurance of Sterility | GenoGenix LLC |
| 30 jul 2025 | copper peptide | II | Lack of Assurance of Sterility | GenoGenix LLC |
| 30 jul 2025 | glutathione | II | Lack of Assurance of Sterility | GenoGenix LLC |
| 29 apr 2014 | glutathione | II | Marketed Without An Approved NDA/ANDA: Parenteral product is labeled for use as an antidote. | Flawless Beauty LLC |
| 29 apr 2014 | glutathione | II | Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling indicates it is to be used parenterally for drug claims. | Flawless Beauty LLC |
| 29 apr 2014 | glutathione | II | Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling includes drug claims to act as an antidote. | Flawless Beauty LLC |
| 27 apr 2016 | somatropin | II | Defective Delivery System; may have a low frequency assembly fault which may result in pens block during the so-called "air shot" step | Novo Nordisk Inc |
| 26 jun 2019 | glutathione | II | Lack of Assurance of Sterility. | First Pharma Associates LLC dba Riverpoint Pharmacy |
| 25 jun 2018 | glutathione | II | Lack of Processing Controls: products produced in a manner that calls into question the sterility of the drug product intended to be sterile. | La Vita Compounding Pharmacy, LLC |
| 25 jun 2014 | glutathione | II | Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer | Medical Supply Liquidators Llc |
| 24 mei 2022 | nicotinamide | II | Lack of Assurance of Sterility | US Specialty Formulations LLC |
| 24 jul 2015 | glutathione | II | Lack of Assurance of Sterility; all sterile human compounded drugs within expiry | JD & SN Inc., dba Moses Lake Professional Pharmacy |
| 24 jul 2015 | glutathione | II | Lack of Assurance of Sterility; all sterile human compounded drugs within expiry | JD & SN Inc., dba Moses Lake Professional Pharmacy |
| 23 mei 2019 | nicotinamide | II | Lack of Sterility Assurance. | Pharm D Solutions, LLC |
| 23 aug 2013 | glutathione | II | Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. | Wellness Pharmacy, Inc. |
| 23 aug 2013 | glutathione | II | Glutathione 100 mg/mL injectable human drug is recalled due to Out Of Specification results or potential bacterial contamination and it was reported as passing by a contract laboratory. | Creative Compounds |
| 22 nov 2023 | nicotinamide | II | Presence of Particulate Matter. | AnazaoHealth Corporation |
| 22 mrt 2018 | glutathione | II | Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization. | Partell Specialty Pharmacy |
| 22 dec 2022 | nicotinamide | II | Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility. | Pharmacy Innovations |
| 22 dec 2022 | nicotinamide | II | Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility. | Pharmacy Innovations |
| 22 dec 2022 | glutathione | II | Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility. | Pharmacy Innovations |
| 21 sep 2016 | glutathione | II | Lack of Assurance of Sterility | Wells Pharmacy Network LLC |
| 21 aug 2018 | glutathione | II | Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile. | Auro Pharmacies, Inc. |
| 2 jun 2015 | glutathione | II | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility | The Compounding Pharmacy of America |
| 2 jun 2015 | glutathione | II | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility | The Compounding Pharmacy of America |
| 2 jan 2019 | glutathione | II | Lack of sterility assurance. | Hiers Enterprises, LLC dba Northwest Compounding Pharmacy |
| 2 jan 2019 | glutathione | II | Lack of sterility assurance. | Hiers Enterprises, LLC dba Northwest Compounding Pharmacy |
| 19 okt 2017 | bimatoprost | III | Failed Impurities/Degradation Specifications. | Allergan Sales, LLC |
| 19 okt 2015 | glutathione | II | Lack of Assurance of Sterility | Western Drug |
| 19 okt 2015 | glutathione | II | Lack of Assurance of Sterility | Western Drug |
| 19 okt 2013 | glutathione | II | Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured. | Specialty Medicine Compounding Pharmacy |
| 19 jun 2019 | glutathione | II | Lack of Assurance of Sterility | RXQ Compounding LLC |
| 19 jun 2019 | nicotinamide | II | Lack of Assurance of Sterility | RXQ Compounding LLC |
| 19 jun 2019 | glutathione | II | Lack of Assurance of Sterility | RXQ Compounding LLC |
| 19 jan 2018 | glutathione | II | Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act. | Flawless Beauty LLC |
| 19 jan 2018 | glutathione | II | Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act. | Flawless Beauty LLC |
| 19 jan 2018 | glutathione | II | Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act. | Flawless Beauty LLC |
| 19 jan 2018 | glutathione | II | Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act. | Flawless Beauty LLC |
| 19 jan 2018 | glutathione | II | Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act. | Flawless Beauty LLC |
| 18 mei 2015 | glutathione | II | Lack of Assurance of Sterility | Advanced Physician Solutions, Inc. |
| 18 jul 2025 | nicotinamide | II | Lack of Processing Controls. | AEQUITA PHARMACY |
| 18 jul 2025 | nicotinamide | II | Lack of Processing Controls. | AEQUITA PHARMACY |
| 18 jul 2025 | nicotinamide | II | Lack of Processing Controls. | AEQUITA PHARMACY |
| 18 jul 2025 | nicotinamide | II | Lack of Processing Controls. | AEQUITA PHARMACY |
| 18 jul 2025 | nicotinamide | II | Lack of Processing Controls. | AEQUITA PHARMACY |
| 18 jul 2025 | nicotinamide | II | Lack of Processing Controls. | AEQUITA PHARMACY |
| 18 jul 2025 | nicotinamide | II | Lack of Processing Controls. | AEQUITA PHARMACY |
| 18 apr 2017 | glutathione | II | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility. | Key Pharmacy and Compounding Center |
| 17 nov 2016 | nicotinamide | II | Lack of Assurance of Sterility | Tri-Coast Pharmacy |
| 17 nov 2016 | nicotinamide | II | Lack of Assurance of Sterility | Tri-Coast Pharmacy |
| 17 nov 2016 | nicotinamide | II | Lack of Assurance of Sterility | Tri-Coast Pharmacy |
| 17 nov 2016 | nicotinamide | II | Lack of Assurance of Sterility | Tri-Coast Pharmacy |
| 17 nov 2016 | nicotinamide | II | Lack of Assurance of Sterility | Tri-Coast Pharmacy |
| 17 nov 2016 | glutathione | II | Lack of Assurance of Sterility | Tri-Coast Pharmacy |
| 17 nov 2016 | nicotinamide | II | Lack of Assurance of Sterility | Tri-Coast Pharmacy |
| 17 nov 2016 | nicotinamide | II | Lack of Assurance of Sterility | Tri-Coast Pharmacy |
| 17 mei 2018 | glutathione | II | Lack of sterility assurance. | Guardian Pharmacy Services |
| 17 mei 2018 | glutathione | II | Lack of sterility assurance. | Guardian Pharmacy Services |
| 17 mei 2018 | glutathione | II | Lack of sterility assurance. | Guardian Pharmacy Services |
| 17 mei 2016 | glutathione | II | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy |
| 17 mei 2016 | glutathione | II | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy |
| 17 dec 2018 | nicotinamide | II | Lack of sterility assurance. | Promise Pharmacy, LLC |
| 17 dec 2018 | glutathione | II | Lack of sterility assurance. | Promise Pharmacy, LLC |
| 17 dec 2018 | nicotinamide | II | Lack of sterility assurance. | Promise Pharmacy, LLC |
| 17 dec 2018 | nicotinamide | II | Lack of sterility assurance. | Promise Pharmacy, LLC |
| 17 dec 2018 | nicotinamide | II | Lack of sterility assurance. | Promise Pharmacy, LLC |
| 16 okt 2015 | glutathione | II | Lack of Assurance of Sterility | Downing Labs, LLC |
| 16 mrt 2017 | bimatoprost | III | Failed Impurities/Degradation Specifications | Allergan Sales, LLC |
| 15 mrt 2021 | semaglutide | II | CGMP Deviations: Intermittent exposure to temperature excursion during storage. | Cardinal Health Inc. |
| 15 mei 2015 | glutathione | II | Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection | Montana Compounding Pharmacy |
| 15 mei 2015 | glutathione | II | Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection | Montana Compounding Pharmacy |
| 15 jan 2020 | glutathione | II | Lack of Assurance of Sterility | Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical |
| 15 aug 2017 | glutathione | II | Lack of Assurance of Sterility. | Bella Pharmaceuticals, Inc. |
| 13 mei 2016 | nicotinamide | II | Lack of Assurance of Sterility | Medaus, Inc. |
| 13 mei 2016 | glutathione | II | Lack of Assurance of Sterility | Medaus, Inc. |
| 13 aug 2021 | glutathione | II | Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns | First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy |
| 13 aug 2021 | glutathione | II | Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns | First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy |
| 12 sep 2019 | glutathione | II | Lack of Assurance of Sterility | KRS Global Biotechnology, Inc |
| 12 dec 2014 | glutathione | II | Incorrect Product Formulation: An incorrect gas was used to remove the oxygen from the vial. | Right Value Drug Stores, Inc. |
| 12 aug 2019 | glutathione | II | Lack of Assurance of Sterility | First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy |
| 12 aug 2019 | glutathione | II | Lack of Assurance of Sterility | First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy |
| 12 aug 2019 | glutathione | II | Lack of Assurance of Sterility | First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy |
| 10 sep 2018 | glutathione | II | Lack of Assurance of Sterility | Pharm D Solutions, LLC |
| 10 feb 2017 | nicotinamide | II | Lack of Assurance of Sterility: There are also CGMP Deviations. | Synergy Rx |
| 10 feb 2017 | nicotinamide | II | Lack of Assurance of Sterility: There are also CGMP Deviations. | Synergy Rx |
| 10 feb 2017 | nicotinamide | II | Lack of Assurance of Sterility: There are also CGMP Deviations. | Synergy Rx |
| 1 nov 2013 | glutathione | II | Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection. | Natures Pharmacy & Compounding Center |
| 1 nov 2013 | glutathione | II | Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection. | Natures Pharmacy & Compounding Center |
| 1 nov 2013 | glutathione | II | Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection. | Natures Pharmacy & Compounding Center |
| 1 nov 2013 | glutathione | II | Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection. | Natures Pharmacy & Compounding Center |
Class I = redelijke kans op ernstige schade · Class II = tijdelijk of omkeerbaar · Class III = onwaarschijnlijk schadelijk.